Health Care·Health Care Equipment·$9.4B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.58 | N/A | +12.84% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.58 | N/A | +12.84% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Overall, management expressed confidence in the company's strategic direction. They noted the importance of maintaining momentum in their core segments.
Management highlighted strong performance in key product areas.
They emphasized ongoing investments in innovation and market expansion.
Baxter's strong EPS performance, exceeding expectations, led to a positive stock reaction, with shares rising by 4.47%. The company did not provide revenue figures or future guidance, leaving some uncertainty. However, management's positive tone suggests they are focused on growth and innovation moving forward.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
CANADIAN NATL RY CO
Apr 24, 2017